NEW YORK (GenomeWeb) – Foundation Medicine and H3 Biomedicine have signed a multi-year collaboration to use genomic data to discover and develop oncology therapeutics, the companies said today.

The partnership marries Foundation Medicine's FoundationCORE, a genomic knowledgebase of more than 35,000 genomic profiles, with H3's drug discovery engine and computational biology platform.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.